Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albany Molecular Research Inc (NASDAQ:AMRI)

15.82
Delayed Data
As of Apr 21
 +0.04 / +0.25%
Today’s Change
12.45
Today|||52-Week Range
19.35
-15.67%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close15.78
Today’s open15.73
Day’s range15.53 - 16.09
Volume765,890
Average volume (3 months)414,409
Market cap$679.2M
Dividend yield--
Data as of 3:59pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)-2,514.29%
Earnings growth (this year)+21.75%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+41.36%
P/E ratioNM
Price/Sales1.26
Price/Book2.27

Competitors

 Today’s
change
Today’s
% change
RGNXRegenxbio Inc-0.05-0.24%
AMRNAmarin Corporation P...-0.01-0.31%
BSTCBiospecifics Technol...-0.63-1.16%
AVXLAnavex Life Sciences...-0.04-0.70%
Data as of 3:59pm ET, 04/21/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$0.13
Annual revenue (last year)$568.8M
Annual profit (last year)-$70.2M
Net profit margin-12.34%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Operating Officer
George Svokos
Corporate headquarters
Albany, New York

Forecasts


Search for Jobs